Article
A common human <i>MLKL</i> polymorphism confers resistance to negative regulation by phosphorylation
2022-09-12
Abstract excerpt
<h4>ABSTRACT</h4> Across the globe, 2-3% of humans carry the p.Ser132Pro single nucleotide polymorphism in MLKL , the terminal effector protein of the inflammatory form of programmed cell death, necroptosis. We show that this substitution confers a gain in necroptotic function in human cells, with more rapid accumulation of activated MLKL S132P in biological membranes and MLKL S132P overriding pharmacological...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4411e365-e2a4-56a2-a44b-38dd9f56aa37
- DOI
- 10.1101/2022.09.08.507056
